BackgroundPulmonary hypertension (PH) is a severe progressive disease characterised by elevated pulmonary vascular resistance and right ventricular hypertrophy. Increasing evidence has highlighted the

NIAID Data Ecosystem60

The down-regulated lncRNAs in the PAH groups compared to the control groups.

肺动脉高压生物标志物

差异表达lncRNA分析

The down-regulated lncRNAs in the PAH groups compared to the control groups.

NIAID Data Ecosystem30

Alterations in Plasma Metabolites in Pulmonary Arterial Hypertension Secondary to Congenital Left-to-Right Shunt Heart Disease

先天性心脏病代谢组学

肺动脉高压生物标志物

Pulmonary arterial hypertension (PAH) secondary to congenital left-to-right shunt heart disease (CL-RSHD) involves vascular remodeling, metabolic dysregulation, chronic inflammation, immune dysfunctio

Figshare2024-10-01 更新60

Table 10_Mitophagy-associated biomarkers and macrophage involvement in pulmonary arterial hypertension: identification and functional implications.xlsx

肺动脉高压生物标志物

线粒体自噬与免疫机制

BackgroundPulmonary arterial hypertension (PAH) is a progressive disorder characterized by pulmonary vascular remodeling and mitochondrial dysfunction. Recent studies have implicated impaired mitophag

NIAID Data Ecosystem50

Correlations between OUE and key abnormal parameters for IPAH patients (N = 32).

资源简介：

相关数据集